remibrutinib
novartis
[]
dr. d rner - interesting question from the audience btk inhibition has been shown to play a role in malignancy within the oncology realm. could this play a role to halt or lower risk of lymphoma in #sjogren patients? answer: not sure. #acr22
Rheumatologist | @ACRheum MarCom Chair | @TexMed Delegate | TexMed Leadership College????? | ???? | Views = Mine | Re-tweet ? endorsement